Gabrielle Tayac, a Native American scholar and historian, still remembers as a girl hearing from her father the oral history passed down in his family for over 100 years: How the town of Indian Head and the highway through it got named. “We were driving down Indian Head Highway, and he said, ‘They killed our people and put their heads on spikes,’” said Tayac, an associate professor at George Mason University. “My father said, ‘That’s why Indian Head was called this.’”
FDA advisers back Novavax COVID shots as 4th US option
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. It’s made with more conventional technology than today’s dominant Pfizer and Moderna shots and the lesser-used Johnson & Johnson option. Novavax shots are already available in Australia, Canada, parts of Europe and multiple other countries, either for initial vaccinations or as mix-and-match boosters. But U.S. clearance is a key hurdle for the Maryland-based company.